COVID-19-Induced Guillain-Barré Syndrome

Joseph E Brooks; Felicia M Mix; Justin C Buck; Reid A Walters

doi:10.7759/cureus.19809

COVID-19-Induced Guillain-Barré Syndrome

Cureus. 2021 Nov 22;13(11):e19809. doi: 10.7759/cureus.19809. eCollection 2021 Nov.

Authors

Joseph E Brooks¹, Felicia M Mix², Justin C Buck³, Reid A Walters⁴

Affiliations

¹ Physical Medicine and Rehabilitation, Genesis Health System, Davenport, USA.
² Physical Medicine and Rehabilitation, Burrell College of Osteopathic Medicine, Las Cruces, USA.
³ Physical Medicine and Rehabilitation, Lincoln Memorial University-DeBusk College of Osteopathic Medicine, Harrogate, USA.
⁴ Physical Medicine and Rehabilitation, Olivet Nazarene University, Bourbonnais, USA.

Abstract

This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). The patient underwent intravenous immune globulin (IVIG) treatment and four weeks of acute inpatient rehabilitation with some functional improvement but remained unable to ambulate independently at discharge.

Keywords: covid 19; covid induced guillian barre syndrome; electrodiagnostic study; electromyography and electro-stimulation; guillain-barre syndrome (gbs).

Publication types

Case Reports